Syndromes Progressive Ataxia Weakness Disorders Market

Treatments for Syndromes of Progressive Ataxia and Weakness Disorders Market - Global Industry Analysis and Forecast to 2020

Treatments for Syndromes of Progressive Ataxia and Weakness Disorders Market Segmented By progressive ataxia syndromes includes Friedreich's ataxia, Gertsman-Straussler-Scheinker disease and Machado-Joseph disease, Progressive Weakness Syndrome such as amyotrophic lateral sclerosis, hereditary spastic paraplegia, hereditary neuropathies, progressive bulbar palsy and multiple sclerosis

Market Overview

Ataxia is a neurological condition, characterized by lack of voluntary coordination of muscle movement. Ataxia causes head trauma, stroke, Transient Ischemic Attack (TIA), tumor and toxic reaction. Progressive ataxia and weakness disorders are related to damage, degeneration or loss of neurons of the brain which leads to muscle coordination disability.

The global market for treatments of syndromes of progressive ataxia and weakness disorders is categorized based on various drugs used for treatment of progressive ataxia syndromes, drugs for progressive weakness syndromes and by technology. The progressive ataxia syndrome segment is further sub-segmented into major diseases, such as Friedreich's ataxia, Gertsman-Straussler-Scheinker disease and Machado-Joseph disease.

The progressive weakness syndrome segment includes amyotrophic lateral sclerosis, hereditary spastic paraplegia, hereditary neuropathies, progressive bulbar palsy and multiple sclerosis. The technology segment is further sub-segmented into small molecules based therapies and monoclonal antibody.

In terms of geography, the U.S. and Canada holds major market share of treatments for syndromes of progressive ataxia and weakness disorders market in North America. In Europe, Germany, France and the U.K are major markets for treatments of syndromes of progressive ataxia and weakness disorders.

Globally, treatments for syndromes of progressive ataxia and weakness disorders market are growing due to novel drug development and rapid technological advancement for treatment of progressive ataxia and weakness disorders.

Some of the major technological advancement involved in growth of the market are protein mis-folding, gene mutation and stem cell therapy. In addition, increased collaborations between industry players for development of new therapies is a key trend for the market.

However, patent expiries of major drugs hampers growth of the treatments for syndromes of progressive ataxia and weakness disorders market. Moreover, stringent regulations and standard requires for approval process of new drugs impede growth of the treatments for syndromes of progressive ataxia and weakness disorders market. Several government agencies, such as FDA and European Medicines Agency, are responsible for the approval of every drug. In addition, the approval process takes a very long time to approve a specific drug.

Some of the major companies operating in the treatment for syndromes of progressive ataxia and weakness disorders market are Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.

Find Out More about the Report Coverage

Key points covered in the report

  • Report segments the market on the basis of types, application, products, technology, etc (as applicable)
  • The report covers geographic segmentation

    • North America
    • Europe
    • Asia
    • RoW
  • The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
  • The report provides company profiles of some of the leading companies operating in the market
  • The report also provides porters five forces analysis of the market.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Recommendations

Norovirus Diagnostics Market

Global norovirus diagnostics market was valued at US$ 47.6 Mn in 2020, and is expected to exhibit a CAGR of around 8.4% over the forecast period (2021-2031)..

Hospital Acquired Infection Control Market

Global Hospital Acquired Infection Control market is expected to be valued US$ 55 Bn & expand at a CAGR of 3% during forecast period of 2021-2026.

Prepackaged Medical Kits Trays Market

The global market for pre-packaged medical kits and trays is anticipated to showcase a stellar CAGR of 8.3% during the forecast period, reaching a market value of over US$ 29,000 Mn by the end of 2026..

Perineal Care Market

Perineal Care Market is expected to register a CAGR of 4.6% from 2017 to 2025. In 2017, the marker was worth US$ 878.2 Mn and it is expected to reach a valuation of US$ 1,254.8 Mn by the end of 2025..

Our Clients

Our Clients